Skip to content

Clinical trials

Not yet recruiting Phase 2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Status: Not yet recruiting Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institut Paoli-Calmettes1
Jonsson Comprehensive Cancer Center1
Medical College of Wisconsin1
Stanford University1
University of Manitoba1
Zhongshan Hospital (Xiamen), Fudan University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders6
Leukemia, Myeloid, Acute3
Myelodysplastic Syndromes3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative1
Leukemia, Myelomonocytic, Chronic1
Myelodysplastic-Myeloproliferative Diseases1
Neoplasm, Residual1
Neutropenia1
Thrombocytosis1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.